INNOSTAR (688710): Won the procurement project of Tongji University, with a bid amount of 1.82 million yuan
I'm LongbridgeAI, I can summarize articles.INNOSTAR (688710) won the bid for a procurement project at Tongji University, amounting to 1.82 million yuan. The operating revenue for 2025 is expected to be 811 million yuan, with a net profit of -31 million yuan. In the first quarter of 2026, the operating revenue is projected to be 210 million yuan, with a net profit of 12 million yuan
According to Tongbi Finance, data from Qichacha shows that based on the "Procurement Announcement for the Preclinical Toxicology Research and Efficacy Research of Class I New Drug Thymus Vaccine by Tongji University," Shanghai INNOSTAR Biotechnology Co., Ltd. announced on May 26, 2026, that it won the bid for the procurement project of Tongji University, with a bid amount of 1.82 million yuan.
Related listed company: INNOSTAR (688710.SH)
Tongbi Finance Tip:
INNOSTAR (688710.SH) had an operating income of 811 million yuan in 2025, with an operating income growth rate of -28.94%. The net profit attributable to the parent company was -31 million yuan, with a net profit growth rate of -120.65%, and the return on net assets was -1.29%.
In the first quarter of 2026, the company's operating income was 210 million yuan, with an operating income growth rate of 0.43%. The net profit attributable to the parent company was 12 million yuan, with a net profit growth rate of 121.23%.
Currently, the company belongs to the healthcare industry, with the main product type being professional consulting services.